Clinical Trial Update: Ammonia N-13 Myocardial Blood Flow Absolute Quantification by PET in Patients With Known or Suspected CAD (Ammonia MAP)

View source ↗

Summary

This ClinicalTrials.gov update reports the completion of a study evaluating ammonia N-13 PET to measure myocardial blood flow in patients with known or suspecte…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Arterial Occlusive Diseases
• Arteriosclerosis
• Cardiovascular Diseases
• Coronary Artery Disease
• Heart Disease
• Myocardial Ischemia
• Vascular Diseases

Snippet

Sponsor: Ionetix Corporation | Conditions: Myocardial Ischemia, Coronary Disease | Status: COMPLETED